In vitro sugar uptake by grapefruit (Citrus paradisi) juice-sac cells.

Funct Plant Biol

Robert H Smith Institute of Plant Sciences and Genetics in Agriculture, The Kennedy-Leigh Centre for Horticultural Research, The Hebrew University of Jerusalem, POB 12, Rehovot 76100, Israel.

Published: May 2005

AI Article Synopsis

  • The study examined how grapefruit juice cells absorb and use different types of sugars, specifically sucrose, glucose, and fructose.
  • The researchers found that glucose and fructose were taken up more quickly than sucrose, and that the uptake rates peaked at certain times during the year, particularly from December to March.
  • The process of sugar uptake was shown to be insatiable, meaning there was no maximum limit to how much sugar the cells could absorb, and metabolic inhibitors slightly reduced sugar uptake and conversion processes.

Article Abstract

To further our understanding of the mechanisms of sugar uptake and accumulation into grapefruit (Citrus paradisi Macf. cv. Marsh seedless), the patterns of uptake and utilisation of sucrose, glucose and fructose by Citrus juice cells was investigated. Analyses were conducted on sliced juice sacs that were incubated in radioactive [C]-sugar solutions with unlabelled sugars, in the presence or absence of metabolic inhibitors. Both hexoses demonstrated an initial uptake peak in December and a second uptake peak in February-March. From March through April the rates of sucrose uptake increased to levels comparable to those of glucose and fructose. Sucrose and its moieties fructose and glucose entered the juice cells of Citrus juice fruit by an insaturable, and mostly by an independent, process. However, NaN and carbonylcyanide m-chlorophenylhydrazone (CCCP) produced slight inhibition of these processes. Cells took up hexoses at a greater rate than sucrose, with accumulation reaching a plateau by 4-8 h, and then continuing unabated, in the case of glucose, for 42 h. Uptake of all three sugars increased linearly in the range of sugar concentrations tested, which extended from 0.01 to 320 mm, denoting an insaturable system for sugar uptake. CO evolution was relatively low in all the experiments, the lowest evolution being recorded when the uptake of [C]-sucrose was studied, while the highest CO evolution was recorded when the uptake of [C]-glucose was studied. The data demonstrate a preferential utilisation of glucose over fructose and sucrose. In all the experiments, the two metabolic inhibitors significantly inhibited the decarboxylation of the three sugars.

Download full-text PDF

Source
http://dx.doi.org/10.1071/FP04125DOI Listing

Publication Analysis

Top Keywords

sugar uptake
12
glucose fructose
12
uptake
10
grapefruit citrus
8
citrus paradisi
8
citrus juice
8
juice cells
8
metabolic inhibitors
8
uptake peak
8
fructose sucrose
8

Similar Publications

Background: Cerebral blood flow (CBF) and glucose utilization have both proven sensitive biomarkers of brain function in Alzheimer's disease. However, while blood flow supplies glucose to cells to meet local demand, and therefore, are inter-related, the two aspects are physiologically distinct. Our goal was to conduct a region-to-region correlation of magnetic resonance imaging (MRI) and F-fluorodeoxyglucose positron emission tomography (FDG-PET) biomarkers of cerebral blood flow and glucose utilization to determine whether these physiologically distinct biomarkers yield functionally distinct information.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Imperial College London, London, UK.

Background: Alzheimer's disease and type 2 diabetes mellitus rank among the top ten leading global causes of death. The association between diabetes and Alzheimer's is linked to chronic low-grade inflammation, hyperinsulinemia, and the interplay between peripheral and central insulin resistance, influencing insulin signalling. We evaluated the association between diabetes and Alzheimer's-related neuropathology in cognitively unimpaired older adults with diabetes.

View Article and Find Full Text PDF

Background: Vascular pathology associated with small vessel disease (SVD), such as microinfarcts and microbleeds, are common in elderly populations and significant contributors to cognitive impairment and dementia. Autosomal dominant cerebral arteriopathy with subcortical infarctions and leukoencephalopathy (CADASIL), caused by mutations in the Notch3 gene, is the most prominent inheritable SVD, with a common etiology of subcortical strokes and dementia. This study aimed to investigate additive or synergistic effects of CADASIL-related vascular alterations and familial Alzheimer's disease (FAD)-related amyloid pathology on cerebral metabolism of glucose and disease progression in a novel FAD-CADASIL mouse model.

View Article and Find Full Text PDF

Background: COVID-19, identified as the greatest health concern of the century, is associated with vascular inflammation and endothelial activation, resulting in multisystemic damage, including to the central nervous system (CNS). Recent investigations indicate a link between endothelial dysfunction, neurological changes, and the development of the so-called long-COVID. Molecules expressed in the endothelium such as P-selectin, E-selectin, and VEGF-A, increased under inflammatory injury, may be associated with conditions like brain injuries and neurodegenerative diseases.

View Article and Find Full Text PDF

Biomarkers.

Alzheimers Dement

December 2024

Alzheimer Center Limburg, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands.

Background: Type 2 diabetes and glucose metabolism have previously been linked to cognitive decline and higher risk of developing Alzheimer's disease (AD) dementia. Yet, the relation of glucose metabolism with amyloid and tau pathology remains unclear. This knowledge will help understanding the importance of glucose regulation in relation to AD.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!